Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for Pain Management in Head and Neck Cancer Patients Undergoing Chemoradiation
NCT03574792Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- May 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venlafaxine in cancer pain, sponsored by Roswell Park Comprehensive Cancer Center. Started May 2018; status: completed.
02
Drugs
venlafaxine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT03574792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03574792.